Lamellipodin, an Ena/VASP Ligand, Is Implicated in the Regulation of Lamellipodial Dynamics
Matthias Krause(University of Mannheim), Frank B. Gertler(Massachusetts Institute of Technology), Geraldine Strasser(IIT@MIT), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Radhika Jagannathan(IIT@MIT), Douglas A. Rubinson(Harvard University), Michael B. Yaffe(Beth Israel Deaconess Medical Center), Jonathan D. Leslie(IIT@MIT), Ferran Valderrama(The Honourable Society of Lincoln's Inn), Mary Q. Stewart(IIT@MIT), Esther M. Lafuente(Universidad Complutense de Madrid), Hui Liu(Second Affiliated Hospital of Zhejiang University), Michael Way(The Francis Crick Institute)
Cited by 342
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k
Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
|Science|1993|914
The complex role of tumor-infiltrating macrophages
|Nature Immunology|2022|859